Systems and methods for the production of human polyclonal antibodies
US11072649B2 · kind B2 · utility
1Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2016 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Nov 25, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in at least two locations of the animal; injecting the animal with an adjuvant in a location of the animal different from the location of the DNA vaccine location; collecting plasma from the animal after the injections; and purifying polyclonal antibody from the plasma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.